Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 74 Records) |
| Query Trace: Neoplasms and CDK12[original query] |
|---|
| Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer. Frontiers in oncology 2022 12 957404. Zhou Jie, Lai Yiming, Peng Shengmeng, Tang Chen, Chen Yongming, Li Lingfeng, Huang Hai, Guo Zhengh |
| Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. Genome medicine 2022 Aug 14 (1): 100. Gong Tingting, Jaratlerdsiri Weerachai, Jiang Jue, Willet Cali, Chew Tracy, Patrick Sean M, Lyons Ruth J, Haynes Anne-Maree, Pasqualim Gabriela, Brum Ilma Simoni, Stricker Phillip D, Mutambirwa Shingai B A, Sadsad Rosemarie, Papenfuss Anthony T, Bornman Riana M S, Chan Eva K F, Hayes Vanessa |
| Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors. Pathology oncology research : POR 2022 8 28 1610360. Wang Hao, Miao Ji, Wen Yazhou, Xia Xihua, Chen Yanan, Huang Mengli, Chen Shiqing, Zhao Zhengyi, Zhang Yuzi, Chen Chunzhu, Zhu Xinh |
| The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer. Clinical genitourinary cancer 2022 7 20 (6): 515-523. Lee Aaron M, Saidian Ava, Shaya Justin, Nonato Taylor, Cabal Angelo, Randall J Michael, Millard Frederick, Stewart Tyler, Rose Brent, Tamayo Pablo, McKay Rana |
| Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer. Frontiers in oncology 2022 7 12 876531. Tang Liansha, Li Wanjiang, Xu Hang, Zheng Xiaonan, Qiu Shi, He Wenbo, Wei Qiang, Ai Jianzhong, Yang Lu, Liu Jiy |
| A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN). In vivo (Athens, Greece) 2022 6 36 (4): 1949-1958. Lee Yong Jae, Seol Aeran, Lee Maria, Kim Jae-Weon, Kim Hee Seung, Kim Kidong, Suh Dong Hoon, Kim Sunghoon, Kim Sang Wun, Lee Jung-Y |
| Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations. Cancer medicine 2022 11 . Li Kai, Cao Li, Li Cheukfai, Wu Jundong, Chen Bo, Zhang Guochun, Li Xueri, Wen Lingzhu, Jia Minghan, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Mok Hsiaopei, Ren Chongyang, Wang Yulei, Qi Xiaofang, Guo Lijie, Che Yue, Liao Ni |
| Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer. JAMA network open 2023 9 6 (9): e2334208. Clara Hwang, Nicholas C Henderson, Shih-Chun Chu, Brandon Holland, Frank C Cackowski, Amanda Pilling, Albert Jang, Shoshana Rothstein, Matthew Labriola, Joseph J Park, Alyssa Ghose, Mehmet A Bilen, Seema Mustafa, Deepak Kilari, Michael J Pierro, Bicky Thapa, Abhishek Tripathi, Rohan Garje, Aditya Ravindra, Vadim S Koshkin, Erik Hernandez, Michael T Schweizer, Andrew J Armstrong, Rana R McKay, Tanya B Dorff, Ajjai S Alva, Pedro C Bara |
| Unique spectrum of activating BRAF alterations in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Alex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, Smruthy Sivakumar, Alexa B Schrock, Hannah E Bergom, Hedyeh Ebrahimi, Sumanta Pal, Tanya Dorff, Neeraj Agarwal, Brandon A Mahal, Geoffrey R Oxnard, Justin Hwang, Emmanuel S Antonarak |
| CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database. Japanese journal of clinical oncology 2023 6 . Kenya Kobayashi, Yuki Saito, Hidenori Kage, Osamu Fukuoka, Koji Yamamura, Toshiyuki Mukai, Katsutoshi Oda, Tatsuya Yamaso |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
| Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial. Cancer medicine 2023 6 . Qingjiang Hu, Eiji Oki, Teppei Yamada, Tomomi Kashiwada, Hideto Sonoda, Masato Kataoka, Hirofumi Kawanaka, Yasushi Tsuji, Akitaka Makiyama, Yuichiro Nakashima, Mitsuhiko Ota, Yasue Kimura, Tomoharu Yoshizu |
| Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide. The Prostate 2023 4 . Albert Jang, Sree M Lanka, Minqi Huang, Crystal V Casado, Sydney A Caputo, Patrick L Sweeney, Kanika Gupta, Olivia Pocha, Nicholas Habibian, Madeline E Hawkins, Alexandra D Lieberman, Jennifer Schwartz, Ellen B Jaeger, Patrick J Miller, Jodi L Layton, Pedro C Barata, Brian E Lewis, Elisa M Ledet, Oliver Sart |
| Prognostic value of genomic mutations in metastatic prostate cancer. Heliyon 2023 3 9 (3): e13827. Zhu Honghui, Ding Yi, Huang Hang, Lin Qi, Chen Wei, Yu Zhixi |
| Homologous recombination repair gene mutations in Malaysian prostate cancer patients. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 22-26. Saeidi Hamidreza, Raju Chandramathi Samudi, Ismail Patimah, Raub Sayyidi Hamzi Abdul, Omar Noorjehan, Hisyam Bakrin Ikm |
| Genetic and clinical landscape of ER?+?/PR- breast cancer in China. BMC cancer 2023 12 23 (1): 1189. Danian Dai, Hongmei Wu, Hongkai Zhuang, Rong Chen, Cheng Long, Bo Ch |
| Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study. Japanese journal of clinical oncology 2023 10 . Takafumi Fukushima, Keisuke Goto, Tetsutaro Hayashi, Kenichiro Ikeda, Tomoya Hatayama, Ryoken Yamanaka, Kyosuke Iwane, Ryo Tasaka, Yuki Kohada, Kenshiro Takemoto, Kohei Kobatake, Akihiro Goriki, Asuka Toshida, Hikaru Nakahara, Masanori Motonaga, Kentaro Tokumo, Yasutoshi Fujii, C Nelson Hayes, Wataru Okamoto, Toshio Kubo, Takashi Matsumoto, Masaki Shiota, Noboru Yamamoto, Yuji Urabe, Eiso Hiyama, Koji Arihiro, Takao Hinoi, Nobuyuki Hina |
| Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis. Urologic oncology 2023 10 . Mohammed Al-Toubat, Samuel Serrano, Ahmed Elshafei, Kashyap Koul, Allison H Feibus, K C Bala |
| Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer. NPJ precision oncology 2024 9 8 (1): 214. Jingyuan Wang, Joanne Xiu, Francesca Battaglin, Hiroyuki Arai, Shivani Soni, Wu Zhang, Richard M Goldberg, Philip A Philip, Andreas Seeber, Jimmy J Hwang, Anthony F Shields, John L Marshall, Igor Astaturov, Tianshu Liu, A Craig Lockhart, W Michael Korn, Lin Shen, Heinz-Josef Le |
| Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis. PloS one 2024 9 19 (9): e0308176. Fernando Ambriz-Barrera, Ernesto Rojas-Jiménez, Clara Estela Díaz-Velásquez, Aldo Hugo De-La-Cruz-Montoya, Héctor Martínez-Gregorio, Miguel Ruiz-De-La-Cruz, Antonio Huertas, Ana Lorena Montealegre, Carlos Castro-Rojas, Gabriela Acosta, Felipe Vaca-Paniagua, Sandra Perdo |
| DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. JCO precision oncology 2024 8 8 e2400014. Laura S Graham, Nicholas C Henderson, Olesia Kellezi, Clara Hwang, Pedro C Barata, Mehmet A Bilen, Deepak Kilari, Michael Pierro, Bicky Thapa, Abhishek Tripathi, George Mo, Matthew Labriola, Joseph J Park, Shoshana Rothstein, Rohan Garje, Vadim S Koshkin, Vaibhav G Patel, Tanya Dorff, Andrew J Armstrong, Rana R McKay, Ajjai Alva, Michael T Schweiz |
| Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer. World journal of urology 2024 8 42 (1): 491. Moritz Hommerding, Oliver Hommerding, Marit Bernhardt, Tobias Kreft, Christine Sanders, Verena Tischler, Patrick Basitta, Natalie Pelusi, Anna-Lena Wulf, Carsten-Henning Ohlmann, Jörg Ellinger, Manuel Ritter, Glen Kristians |
| Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China. Journal of Cancer 2024 7 15 (14): 4467-4476. Gang Ma, Binliang Huo, Yanwei Shen, Xulong Zhu, Chong Cheng, Wensheng Li, Wei Cao, Jianhui |
| Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer. BJU international 2024 7 . Mike Wenzel, Benedikt Hoeh, Florestan Koll, Clara Humke, Anne Fassl, Henning Reis, Peter Wild, Thomas Steuber, Markus Graefen, Derya Tilki, Miriam Traumann, Severine Banek, Felix K H Chun, Philipp Mand |
| Analysis of Breast Cancer Brain Metastases Reveals an Enrichment of Cyclin-Dependent Kinase 12 Structural Rearrangements in Human Epidermal Growth Factor Receptor 2-Positive Disease. JCO precision oncology 2024 6 8 e2300639. Talvinder Bhogal, Athina Giannoudis, Ethan Sokol, Simak Ali, Carlo Palmie |
| Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer. Molecular cytogenetics 2024 5 17 (1): 11. William Lautert-Dutra, Camila M Melo, Luiz P Chaves, Cheryl Crozier, Fabiano P Saggioro, Rodolfo B Dos Reis, Jane Bayani, Sandro L Bonatto, Jeremy A Squi |
| Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 5 . Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai S Al |
| Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. European urology open science 2024 12 71 38-48. Ursula Lemberger, Büsra Ernhofer, Sigurd Krieger, Andreas Bruchbacher, André Oszwald, Ekaterina Laukhtina, Andrea Haitl, Melanie R Hassler, Bernhard Englinger, Eva Compérat, Shahrokh F Shari |
| Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer. Nature cancer 2024 11 . Yang Yang, Michelle L Badura, Patrick C O'Leary, Henry M Delavan, Troy M Robinson, Emily A Egusa, Xiaoming Zhong, Jason T Swinderman, Haolong Li, Meng Zhang, Minkyu Kim, Alan Ashworth, Felix Y Feng, Jonathan Chou, Lixing Ya |
| Large tandem duplications in cancer result from transcription and DNA replication collisions. medRxiv : the preprint server for health sciences 2024 1 . Yang Yang, Michelle L Badura, Patrick C O'Leary, Henry M Delavan, Troy M Robinson, Emily A Egusa, Xiaoming Zhong, Jason T Swinderman, Haolong Li, Meng Zhang, Minkyu Kim, Alan Ashworth, Felix Y Feng, Jonathan Chou, Lixing Ya |
- Page last reviewed:Feb 1, 2024
- Content source: